Orbimed Advisors LLC Guardant Health, Inc. Transaction History

Orbimed Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $1.79 Million - $2.5 Million	-41,000 Reduced 3.97%	992,400 $53.4 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $8.42 Million - $22.6 Million	-292,000 Reduced 22.03%	1,033,400 $41.7 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $4.73 Million - $9.85 Million	98,000 Added 7.98%	1,325,400 $87.8 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $27.4 Million - $41.4 Million	250,000 Added 25.58%	1,227,400 $152 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $55.8 Million - $78.7 Million	439,200 Added 81.61%	977,400 $149 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $38.4 Million - $52.2 Million	383,900 Added 248.8%	538,200 $69.4 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $12.4 Million - $17.3 Million	154,300 New	154,300 $17.2 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $98.1 Million - $140 Million	-1,534,464 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $44.8 Million - $70.7 Million	1,534,464 New	1,534,464 $57.7 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.